DNA and RNA Molecules as a Foundation of Therapy Strategies for Treatment of Cardiovascular DiseasesPHARMACEUTICSIF5.52023-08-150OAAI
Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision MedicineCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52018-06-194PREAI
Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activityARCHIVES OF BIOCHEMISTRY AND BIOPHYSICSIF32015-03-0110PREAI
GENOTYPE CYP2C19 EFFECTS ON THERAPEUTIC RESPONSE DURING CLOPIDOGREL TREATMENT IN PATIENTS WITH CAROTID ARTERY STENOSISTHROMBOSIS RESEARCHIF3.42014-05-010PREAI
Clinical characteristics of the first thrombosis process among young women and those over 45 yearsTHROMBOSIS RESEARCHIF3.42013-01-010PREAI
Pharmacogenetic tests could be helpful in predicting of VKA maintenance dose in elderly patients at treatment initiationTHROMBOSIS RESEARCHIF3.42012-10-010PREAI
A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor proteinARCHIVES OF BIOCHEMISTRY AND BIOPHYSICSIF32010-10-0169PREAI
The use of D-dimer with new threshold in diagnosis of venous thromboembolism in pregnancyTHROMBOSIS RESEARCHIF3.42009-01-010PREAI